Applied Consumer Neuroscience Labs Ltd. 10050864 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is research and experimental development on social sciences and humanities. Digita Accounts Production Advanced 6.30.9574.0 true 10050864 2023-04-01 2024-03-31 10050864 2024-03-31 10050864 core:CurrentFinancialInstruments 2024-03-31 10050864 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10050864 bus:SmallEntities 2023-04-01 2024-03-31 10050864 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10050864 bus:FullAccounts 2023-04-01 2024-03-31 10050864 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10050864 bus:RegisteredOffice 2023-04-01 2024-03-31 10050864 bus:Director1 2023-04-01 2024-03-31 10050864 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10050864 countries:EnglandWales 2023-04-01 2024-03-31 10050864 2022-04-01 2023-03-31 10050864 2023-03-31 10050864 core:CurrentFinancialInstruments 2023-03-31 10050864 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 10050864

Applied Consumer Neuroscience Labs Ltd.

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

Applied Consumer Neuroscience Labs Ltd.

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 4

 

Applied Consumer Neuroscience Labs Ltd.

(Registration number: 10050864)
Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

6,308

18,229

Cash at bank and in hand

 

12,574

7,951

 

18,882

26,180

Creditors: Amounts falling due within one year

5

(22,987)

(22,013)

Net (liabilities)/assets

 

(4,105)

4,167

Capital and reserves

 

Called up share capital

150

150

Retained earnings

(4,255)

4,017

Shareholders' (deficit)/funds

 

(4,105)

4,167

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 September 2024 and signed on its behalf by:
 

.........................................
Prof D C Richardson
Director

 

Applied Consumer Neuroscience Labs Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Applied Consumer Neuroscience Labs Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 3).

4

Debtors

Current

2024
£

2023
£

Trade debtors

4,800

12,000

Prepayments

265

2,310

Other debtors

1,243

3,919

 

6,308

18,229

 

Applied Consumer Neuroscience Labs Ltd.

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

5

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

4,525

3,260

Other creditors

18,462

18,753

22,987

22,013

6

Related party transactions

Other transactions with directors

J Hogan (director) had a loan account with the company. At the balance sheet date the amount due to J Hogan was £4,804 (2023 - £4,804).

J Devlin (director) had a loan account with the company. At the balance sheet date the amount due to J Devlin was £10,991 (2023 - £10,991).

D Richardson (director) had a loan account with the company. At the balance sheet date the amount due from/(to) D Richardson was £1,243 (2023 - £291).